Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History NBTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics NBTX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Nanobiotix

NBTX
Current price
4.42 USD +0.035 USD (+0.80%)
Last closed 4.47 USD
ISIN US63009J1079
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 209 008 800 USD
Yield for 12 month +1.26 %
1Y
3Y
5Y
10Y
15Y
NBTX
21.11.2021 - 28.11.2021

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France. Address: 60 rue de Wattignies, Paris, France, 75012

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.52 USD

P/E ratio

Dividend Yield

Financials NBTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures NBTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

-13 378 786 USD

Last Year

+41 727 891 USD

Current Quarter

-24 083 889 USD

Last Quarter

+10 705 103 USD

Current Year

-13 378 786 USD

Last Year

+41 727 891 USD

Current Quarter

-24 083 889 USD

Last Quarter

+10 705 103 USD
EBITDA -67 666 000 USD
Operating Margin TTM 271.42 %
Price to Earnings
Return On Assets TTM -52.89 %
PEG Ratio
Return On Equity TTM -198.69 %
Wall Street Target Price 7.52 USD
Revenue TTM -7 190 000 USD
Book Value -1.39 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 182.10 %
Dividend Yield
Gross Profit TTM -7 190 000 USD
Earnings per share -1.66 USD
Diluted Eps TTM -1.66 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation NBTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 48.31
Enterprise Value Revenue 3.39
Price Sales TTM 3.82
Enterprise Value EBITDA -2.45
Price Book MRQ 65.02

Technical indicators NBTX

For 52 weeks

2.76 USD 6.00 USD
50 Day MA 3.81 USD
Shares Short Prior Month 62 284
200 Day MA 3.90 USD
Short Ratio 0.55
Shares Short 6 794
Short Percent 0.020 %